Theriva Biologics (TOVX) Short Interest Ratio & Short Volume $0.44 -0.01 (-1.56%) Closing price 07/3/2025 05:00 PM EasternExtended Trading$0.44 0.00 (-0.68%) As of 07/3/2025 05:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestBuy This Stock Theriva Biologics Short Interest DataTheriva Biologics (TOVX) has a short interest of 249,400 shares, representing 2.78% of the float (the number of shares available for trading by the public). This marks a 157.38% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 1.35 million shares to cover all short positions.Current Short Interest249,400 sharesPrevious Short Interest96,900 sharesChange Vs. Previous Month+157.38%Dollar Volume Sold Short$119.64 thousandShort Interest Ratio0.2 Days to CoverLast Record DateJune 15, 2025Outstanding Shares8,190,000 sharesFloat Size8,960,000 sharesShort Percent of Float2.78%Today's Trading Volume64,877 sharesAverage Trading Volume1,350,451 sharesToday's Volume Vs. Average5% Short Selling Theriva Biologics? Sign up to receive the latest short interest report for Theriva Biologics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTOVX Short Interest Over TimeTOVX Days to Cover Over TimeTOVX Percentage of Float Shorted Over Time Theriva Biologics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/2025249,400 shares $119.64 thousand +157.4%2.8%0.2 $0.48 5/31/202596,900 shares $44.55 thousand -43.9%1.2%0.1 $0.46 5/15/2025172,700 shares $93.26 thousand +133.4%2.1%0.2 $0.54 4/30/202574,000 shares $99.90 thousand -23.5%2.7%0.1 $1.35 4/15/202596,700 shares $132.83 thousand +22.4%3.5%1.6 $1.37 3/31/202579,000 shares $86.90 thousand +12.5%2.9%0.7 $1.10 3/15/202570,200 shares $81.01 thousand -16.9%2.6%0.2 $1.15 2/28/202584,500 shares $121.68 thousand -49.6%3.1%0.2 $1.44 2/15/2025167,500 shares $0.00 -36.1%6.1%0.4 $0.00 1/31/2025262,100 shares $0.00 -13.7%9.5%0.6 $0.00 Get the Latest News and Ratings for TOVX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Theriva Biologics and its competitors with MarketBeat's FREE daily newsletter. 1/15/2025303,700 shares $0.00 +11.0%11.0%0.2 $0.00 12/31/2024273,500 shares $0.00 +108.1%10.0%0.1 $0.00 12/15/2024131,400 shares $0.00 +66.5%4.8%0 $0.00 11/30/202478,900 shares $0.00 -23.6%2.9%0 $0.00 11/15/2024103,300 shares $0.00 +13.5%3.8%0 $0.00 10/31/202491,000 shares $0.00 +15.2%4.1%0 $0.00 10/15/202479,000 shares $0.00 -18.5%3.6%0 $0.00 9/30/202496,900 shares $0.00 +6.5%4.4%0.1 $0.00 9/15/202491,000 shares $0.00 -62.9%6.8%0.2 $0.00 8/31/2024245,200 shares $0.00 +6,030.0%24.8%0.4 $0.00 8/15/20244,000 shares $0.00 -91.4%0.0%0.1 $0.00 7/31/202446,300 shares $0.00 +60.2%0.3%0.1 $0.00 7/15/202428,900 shares $0.00 -93.7%0.2%0 $0.00 6/30/2024457,800 shares $0.00 -21.7%2.7%0.8 $0.00 6/15/2024584,300 shares $0.00 -14.5%3.5%1 $0.00 5/31/2024683,200 shares $0.00 +67.7%4.0%1.2 $0.00 5/15/2024407,300 shares $0.00 -18.3%2.4%0.8 $0.00 4/30/2024498,600 shares $0.00 +26.3%3.0%3.3 $0.00 4/15/2024394,800 shares $0.00 -3.9%2.4%3 $0.00 3/31/2024411,000 shares $0.00 +13.4%2.5%4.2 $0.00 3/15/2024362,600 shares $0.00 +4.1%2.2%3.3 $0.00 2/29/2024348,200 shares $0.00 +0.7%2.1%5.4 $0.00 2/15/2024345,800 shares $0.00 -1.0%2.1%5.2 $0.00 1/31/2024349,100 shares $0.00 -4.2%2.1%5 $0.00 1/15/2024364,500 shares $0.00 +5.4%2.2%6.1 $0.00 12/31/2023345,800 shares $0.00 -8.4%2.1%5.8 $0.00 12/15/2023377,400 shares $0.00 -2.0%2.3%6.9 $0.00 11/30/2023384,900 shares $0.00 +9.4%2.3%8.7 $0.00 11/15/2023351,900 shares $0.00 -14.9%2.1%8.2 $0.00 10/31/2023413,400 shares $0.00 -3.5%2.5%8.9 $0.00White House to reset Social Security? (Ad)Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington. And it could have a major impact on how you collect Social Security - Click here to understand what' 10/15/2023428,200 shares $0.00 +5.6%2.6%7.2 $0.00 9/30/2023405,600 shares $0.00 -14.6%2.4%5.4 $0.00 9/15/2023474,800 shares $0.00 +8.1%2.8%0.6 $0.00 8/31/2023439,100 shares $0.00 +5.9%2.6%0.6 $0.00 8/15/2023414,700 shares $0.00 -5.3%2.5%0.6 $0.00 7/31/2023437,900 shares $0.00 -9.7%3.0%0.6 $0.00 7/15/2023484,700 shares $0.00 -76.5%3.3%0.7 $0.00 6/30/20232,060,000 shares $0.00 +413.1%13.9%3 $0.00 6/15/2023401,500 shares $0.00 +5.8%2.7%5.3 $0.00 5/31/2023379,400 shares $0.00 -1.6%2.6%11.9 $0.00 5/15/2023385,500 shares $0.00 No Change2.6%11.7 $0.00 TOVX Short Interest - Frequently Asked Questions What is Theriva Biologics' current short interest? Short interest is the volume of Theriva Biologics shares that have been sold short but have not yet been closed out or covered. As of June 15th, traders have sold 249,400 shares of TOVX short. 2.78% of Theriva Biologics' shares are currently sold short. Learn More on Theriva Biologics' current short interest. What is a good short interest percentage for Theriva Biologics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.78% of Theriva Biologics' floating shares are currently sold short. Is Theriva Biologics' short interest increasing or decreasing? Theriva Biologics saw a increase in short interest during the month of June. As of June 15th, there was short interest totaling 249,400 shares, an increase of 157.4% from the previous total of 96,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Theriva Biologics' float size? Theriva Biologics currently has issued a total of 8,190,000 shares. Some of Theriva Biologics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Theriva Biologics currently has a public float of 8,960,000 shares. How does Theriva Biologics' short interest compare to its competitors? 2.78% of Theriva Biologics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Theriva Biologics: X4 Pharmaceuticals, Inc. (12.63%), ProPhase Labs, Inc. (0.47%), VYNE Therapeutics Inc. (2.53%), Synlogic, Inc. (0.53%), Allarity Therapeutics, Inc. (5.65%), 23andMe Holding Co. (11.90%), GeoVax Labs Inc. (3.59%), EOM Pharmaceutical Holdings, Inc. (0.00%), NextCure, Inc. (1.22%), China Health Industries Holdings, Inc. (0.00%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks. What does it mean to sell short Theriva Biologics stock? Short selling TOVX is an investing strategy that aims to generate trading profit from Theriva Biologics as its price is falling. TOVX shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Theriva Biologics? A short squeeze for Theriva Biologics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TOVX, which in turn drives the price of the stock up even further. How often is Theriva Biologics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TOVX, twice per month. The most recent reporting period available is June, 15 2025. More Short Interest Resources from MarketBeat Related Companies X4 Pharmaceuticals Short Interest ProPhase Labs Short Interest VYNE Therapeutics Short Interest Synlogic Short Interest Allarity Therapeutics Short Interest 23andMe Short Interest GeoVax Labs Short Interest EOM Pharmaceutical Short Interest NextCure Short Interest China Health Industries Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSEAMERICAN:TOVX) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredThe #1 AI Energy StockNearly $600 billion is projected to be spent on AI data centers this year. That's because the ones being bu...Weiss Ratings | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Theriva Biologics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Theriva Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.